Response to comment on Goldfine et al. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes care 2013;36:4132-4139

Diabetes Care. 2014 May;37(5):e112. doi: 10.2337/dc14-0222.
No abstract available

Publication types

  • Comment

MeSH terms

  • Blood Glucose / metabolism*
  • Diabetes Mellitus, Type 2 / blood*
  • Endothelium, Vascular / physiopathology*
  • Female
  • Humans
  • Inflammation / drug therapy*
  • Male
  • Salicylates / administration & dosage*
  • Vasodilation / drug effects*

Substances

  • Blood Glucose
  • Salicylates